Neurogene Inc
NASDAQ:NGNE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Neurogene Inc
NASDAQ:NGNE
|
US |
|
Impax Asset Management Group PLC
LSE:IPX
|
UK |
|
O
|
Opticept Technologies AB
STO:OPTI
|
SE |
|
C
|
China Star Food Group Ltd
SGX:42W
|
SG |
|
ANZ Group Holdings Ltd
OTC:ANZGF
|
AU |
Wall Street
Price Targets
NGNE Price Targets Summary
Neurogene Inc
According to Wall Street analysts, the average 1-year price target for
NGNE
is 79.22 USD
with a low forecast of 46.46 USD and a high forecast of 189 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is NGNE's stock price target?
Price Target
79.22
USD
According to Wall Street analysts, the average 1-year price target for
NGNE
is 79.22 USD
with a low forecast of 46.46 USD and a high forecast of 189 USD.